13th Annual Multidisciplinary
Genitourinary Oncology Course
November 19, 2013
InterContinental Hotel & Bank of America Conference Center
Urologic neoplasms represent the model for multidisciplinary management. With the rapid increase in our understanding of tumor biology and its extension into the clinic, there is an ever-expanding therapeutic armamentarium available to manage patients with testicular, bladder, prostate and renal cell carcinoma. This one-day course is designed to provide a topical, clinically-based overview of many of the current therapy dilemmas faced by clinicians managing GU neoplasms, with an emphasis on the opportunities for multidisciplinary management.
Urologists, medical and radiation oncologists, and other health care providers with an interest in the management of patients with urologic malignancies should attend this course.
After participating in the course, the participant will:
- Recognize the significant interaction required of urologists, medical oncologists, and radiation oncologists in the optimal management of patients with urologic neoplasms.
- Discriminate better between the potential therapeutic options available for patients with prostate, bladder, kidney and testicular neoplasms.
- Integrate evolving knowledge of radiotherapy in the management of prostate cancer.
- Utilize evolving therapeutic options in patients with advanced bladder, prostate, and kidney neoplasms.
To expedite your registration, please fax your form to the Cleveland Clinic Taussig Cancer Institute
Once faxed, do not send original registration form.
Mail registration form to:
Cleveland Clinic Taussig Cancer Institute
9500 Euclid Ave. R-26
Cleveland, OH 44195